Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Toxins (Basel) ; 13(3)2021 03 02.
Artículo en Inglés | MEDLINE | ID: mdl-33801318

RESUMEN

Wound necrosis and secondary infection are common complications after Naja atra bites. Clinical tools to evaluate the infection risk after Taiwan cobra bites are lacking. In this Cobra BITE study, we investigated the prevalence of wound infection, bacteriology, and corresponding antibiotic usage in patients presenting with Taiwan cobra snakebites. Patients with wound infection lacking tissue necrosis were included in developing Cobra BITE score utilizing univariate and multiple logistic regression, as patients with wound necrosis require antibiotics for infection treatment. 8,295,497 emergency department visits occurred in the span of this study, with 195 of those patients being diagnosed as having cobra bites. Of these patients, 23 had wound necrosis, and 30 had wound infection, resulting in a wound infection rate of 27.2% (53/195). Enterococcus faecalis and Morganella morganii were the main bacteria identified in the culture report regardless of whether patients' wounds had necrosis. As per our Cobra BITE score, the three factors predicting secondary wound infection after cobra bites are hospital admission, a white blood cell count (in 103/µL) × by neu-trophil-lymphocyte ratio value of ≥114.23, and the use of antivenin medication. The area under the receiver operating characteristic curve for the Cobra BITE score system was 0.88; ideal sensitivity and specificity were 0.89 and 0.76. This scoring system enables the assessment of wound infections after N. atra bites, and it could be modified and improved in the future for other Naja spp. bites.


Asunto(s)
Antibacterianos/uso terapéutico , Antivenenos/uso terapéutico , Venenos Elapídicos/antagonistas & inhibidores , Enterococcus faecalis/efectos de los fármacos , Morganella morganii/efectos de los fármacos , Naja naja , Mordeduras de Serpientes/tratamiento farmacológico , Infección de Heridas/tratamiento farmacológico , Adulto , Anciano , Animales , Técnicas de Apoyo para la Decisión , Venenos Elapídicos/inmunología , Enterococcus faecalis/aislamiento & purificación , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Morganella morganii/aislamiento & purificación , Necrosis , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Mordeduras de Serpientes/diagnóstico , Mordeduras de Serpientes/microbiología , Resultado del Tratamiento , Infección de Heridas/diagnóstico , Infección de Heridas/microbiología
3.
Perit Dial Int ; 37(2): 241-242, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28360373

RESUMEN

Morganella morganii is a rare cause of peritonitis in patients on peritoneal dialysis (PD). Most of the reported cases have resorted to a switch to hemodialysis. We herein report a case of peritonitis due to M. morganii resistant to third-generation cephalosporins, which was treated successfully with intraperitoneal (IP) tobramycin followed by oral ciprofloxacin. Early microbiologic diagnosis is essential in the treatment of peritonitis from rare microorganisms such as Morganella morganii, and appropriate antibiotic therapy is the key to avoiding catheter loss and subsequent switch to hemodialysis.


Asunto(s)
Ciprofloxacina/administración & dosificación , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Diálisis Peritoneal/efectos adversos , Peritonitis/tratamiento farmacológico , Peritonitis/microbiología , Tobramicina/administración & dosificación , Centros Médicos Académicos , Administración Oral , Cefalosporinas/administración & dosificación , Farmacorresistencia Microbiana , Quimioterapia Combinada , Infecciones por Enterobacteriaceae/diagnóstico , Femenino , Estudios de Seguimiento , Humanos , Infusiones Parenterales , Fallo Renal Crónico/diagnóstico , Fallo Renal Crónico/terapia , Persona de Mediana Edad , Morganella morganii/efectos de los fármacos , Morganella morganii/aislamiento & purificación , Diálisis Peritoneal/métodos , Peritonitis/etiología , Resultado del Tratamiento
4.
ANZ J Surg ; 83(5): 365-70, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-22989238

RESUMEN

BACKGROUND: The aim of this study was to describe the clinical characteristics, causative pathogens, clinical management and outcomes of patients presenting to a tertiary adult Australian intensive care unit (ICU) with a diagnosis of necrotizing fasciitis (NF). METHODS: This retrospective observational study was conducted in a 19-bed, level III, adult ICU in a 450-bed tertiary, regional hospital. Clinical databases were accessed for patients diagnosed with NF and admitted to The Geelong Hospital ICU between 1 February 2000 and 1 June 2011. Information on severity of sepsis, surgical procedures and microbiological results were collected. RESULTS: Twenty patients with NF were identified. The median age was 52.5 years and 38% were female. The overall mortality rate was 8.3%. Common co-morbidities were diabetes (21%) and heart failure (17%), although 50% of patients had no co-morbidities. Group A Streptococcus was the identified pathogen in 11 (46%) patients, and Streptococcus milleri group in 5 (21%) patients. Hyperbaric oxygen therapy was not used in the majority of patients. The initial antibiotics administered were active against subsequently cultured bacteria in 83% of patients. Median time to surgical debridement was 20 h. Diagnosis and management was delayed in the nosocomial group. CONCLUSIONS: This study reports physiological data, aetiology and therapeutic interventions in NF for an adult tertiary hospital. We demonstrate one of the lowest reported mortality rates, with early surgical debridement being achieved in the majority of patients. The main delay was found to be in the diagnosis of NF.


Asunto(s)
Infecciones por Enterobacteriaceae , Fascitis Necrotizante , Infecciones por Bacterias Grampositivas , Antibacterianos/uso terapéutico , Estudios de Cohortes , Terapia Combinada , Infección Hospitalaria/diagnóstico , Infección Hospitalaria/mortalidad , Infección Hospitalaria/terapia , Desbridamiento , Diagnóstico Precoz , Infecciones por Enterobacteriaceae/diagnóstico , Infecciones por Enterobacteriaceae/microbiología , Infecciones por Enterobacteriaceae/mortalidad , Infecciones por Enterobacteriaceae/terapia , Fascitis Necrotizante/diagnóstico , Fascitis Necrotizante/microbiología , Fascitis Necrotizante/mortalidad , Fascitis Necrotizante/terapia , Femenino , Infecciones por Bacterias Grampositivas/diagnóstico , Infecciones por Bacterias Grampositivas/microbiología , Infecciones por Bacterias Grampositivas/mortalidad , Infecciones por Bacterias Grampositivas/terapia , Humanos , Oxigenoterapia Hiperbárica , Unidades de Cuidados Intensivos , Masculino , Persona de Mediana Edad , Morganella morganii/aislamiento & purificación , Estudios Retrospectivos , Infecciones Estreptocócicas/diagnóstico , Infecciones Estreptocócicas/microbiología , Infecciones Estreptocócicas/mortalidad , Infecciones Estreptocócicas/terapia , Streptococcus milleri (Grupo)/aislamiento & purificación , Streptococcus pyogenes/aislamiento & purificación , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA